Concepedia

Bodvaël Pennarun

BP

Statistics

Publications

8

Citations

224

H-Index

8

Active since

2010

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

University of Groningen

Institute of Biochemistry

University Medical Center Groningen

Bodvaël Pennarun is an author at Harvard University specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2010–2017

8

Publications

8

A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7

Barbara Hopkins, Monica J. S. Nadler, John Skoko et al. · Antioxidants and Redox Signaling · 2017 · 64 citations · Full text

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5

Caroline MM van Geelen, Bodvaël Pennarun, Phuong Le et al. · BMC Cancer · 2011 · 35 citations · Full text

Targeting <scp>FLIP</scp> and Mcl‐1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to <scp>TRAIL</scp>

Bodvaël Pennarun, Jan H. Kleibeuker, Wytske Boersma‐ van Ek et al. · The Journal of Pathology · 2012 · 29 citations

, , +19

A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death

Octavian Bucur, Gabriel Gaidos, Achani K. Yatawara et al. · Scientific Reports · 2015 · 28 citations · Full text

Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells

Octavian Bucur, Andreea Lucia Stancu, Ioana Goganau et al. · PLoS ONE · 2013 · 24 citations · Full text

1–5 of 8